£57.0M
The Series C financing was led by Elevage Medical Technologies with backing from Patient Square Capital and other investors.
Nuclera
Nuclera develops benchtop systems to accelerate protein expression and purification for research laboratories.
£88.4MTotal raised
Nuclera builds benchtop protein systems designed to accelerate expression and purification workflows in research laboratories. The biotechnology enterprise operates out of bases in Cambridge and Boston.
Categories
Founders
MC
Michael Chen
CEO
TO
Tobias Ost
Co-founder
Investors
- £57.0M
- £31.4M
Funding history
£31.4M
The Cambridge biotechnology company has raised £31.4m from investors including M&G and Amadeus Capital Partners to advance its desktop protein printer.